
|Articles|February 23, 2022
Daily Medication Pearl: Dorzolamide/Timolol (Cosopt)
Author(s)Saro Arakelians, PharmD
Dorzolamide/timolol (Cosopt) is indicated for patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.
Advertisement
Medication Pearl of the Day: Dorzolamide/Timolol (Cosopt)
Indication: Dorzolamide/timolol(Cosopt) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.
Insight:
- Dosing: The dose is 1 drop of Cosopt in the affected eye(s) twice daily.
- Dosage forms: 10 mL in an 18 mL capacity bottle.
- Adverse events: The most frequently reported adverse events were taste perversion (bitter, sour, or unusual taste) or ocular burning and/or stinging in up to 30% of patients. Conjunctival hyperemia, blurred vision, superficial punctate keratitis, or eye itching were reported between 5% and 15% of patients.
- Mechanism of action: Cosopt is comprised of 2 components: dorzolamide hydrochloride and timolol maleate. Each of these components decreases elevated intraocular pressure, whether associated with glaucoma, by reducing aqueous humor secretion.
- Manufacturer: Merck
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
UConn’s Medical Writing Certificate Program: It’s Just "Write"
3
Pharmacy Policy Updates for October 2025
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5